Nicole Karam

Interventional cardiologist / Cardiologist
Clemenceau Medical Center -

Latest contributions

Advancing TAVI practice

21 May 2026 – From EuroPCR 2026

Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

20 May 2026 – From EuroPCR 2026

This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

Innovations in structural interventions

20 May 2026 – From EuroPCR 2026

Highlighting the forefront of structural heart interventions, this session presents innovations including novel devices and technologies from industry leaders. It features advancements such as a new transseptal left atrial fixation device designed to expand the suitability of transcatheter mitral valve replacement (TMVR).

Structural heart devices: what's new and how it reaches your cathlab

20 May 2026 – From EuroPCR 2026

Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...

Innovating heart failure care: from real-time monitoring to mechanical support

18 May 2026 – From EuroPCR 2026

Innovations in heart failure care are transforming patient management, from real-time, non-invasive congestion monitoring to advanced mechanical support systems. This session presents the Anusar congestion assessment tool, early clinical data on the NuPulse intravascular ventricular assist system for ambulatory support, and explores AI-driven voice biomarker technology...